{"disease":{"id":"borderline-ovarian-tumors","name":"borderline ovarian tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06709872","title":"A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline from Stage I Invasive Ovarian Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"KU Leuven","has_results":false},{"nct_id":"NCT03690440","title":"Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian Tumor","phase":"","overall_status":"COMPLETED","enrollment_count":176,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT03779399","title":"Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Medical University of Lublin","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}